Schedule 13G ownership disclosure

Harmony Biosciences Holdings Inc

Common Stock, $0.00001 par value per share · CUSIP: 413197104

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Valor IV Pharma Holdings, LLC

    Shares: 6,618,033.00 · Class: 11.6%

  • Valor Equity Partners IV L.P.

    Shares: 5,117,088.00 · Class: 9.0%

  • Valor Equity Partners IV-A L.P.

    Shares: 281,739.00 · Class: 0.5%

  • Valor Equity Partners IV-B L.P.

    Shares: 1,219,206.00 · Class: 2.1%

  • Valor Equity Associates IV L.P.

    Shares: 6,618,033.00 · Class: 11.6%

  • Valor Equity Capital IV LLC

    Shares: 6,618,033.00 · Class: 11.6%

  • Valor Management L.P.

    Shares: 6,618,033.00 · Class: 11.6%

  • Antonio J. Gracias

    Shares: 6,654,747.00 · Class: 11.7%

  • Juan A. Sabater

    Shares: 6,644,257.00 · Class: 11.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-25-013077
Form type
SCHEDULE 13G/A
Filer
Harmony Biosciences Holdings, Inc.
CIK
CIK 1802665
Filed
Feb 12, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub